SCHEMBL13627307

SCHEMBL13627307

CCNC(=O)Nc1cc(Oc2ccnc3cc(OC)c(C(=O)NC)cc23)ccc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 3/20 0.54
KDR P35968 16/20 0.54
MET P08581 7/20 0.54
AURKB Q96GD4 6/20 0.54
LCK P06239 5/20 0.54
TEK Q02763 5/20 0.54
AURKA O14965 4/20 0.54
PDGFRA P16234 10/20 0.53
KIT P10721 4/20 0.49
FGFR2 P21802 3/20 0.49
RIPK2 O43353 3/20 0.49
RET P07949 3/20 0.49
PDGFRB P09619 3/20 0.49
FGFR1 P11362 3/20 0.49
FLT1 P17948 3/20 0.49
FLT4 P35916 3/20 0.49
DDR1 Q08345 3/20 0.49
DDR2 Q16832 3/20 0.49
FGFR3 P22607 2/20 0.49
STK10 O94804 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12673919 0.93 KDR (0.59) AXLKDRMETAURKBLCK
SCHEMBL1896779 0.90 KDR (0.57) AXLKDRMETAURKBLCK
SCHEMBL863892 0.89 KDR (0.62) AXLKDRMETAURKBLCK
SCHEMBL13627611 0.88 KDR (0.61) AXLKDRMETAURKBLCK
SCHEMBL14437505 0.87 AXL (0.52) AXLKDRMETAURKBLCK
SCHEMBL12664717 0.84 AXL (0.50) AXLKDRMETAURKBLCK
SCHEMBL12499932 0.84 KDR (0.59) AXLKDRMETAURKBLCK
SCHEMBL6796519 0.83 KDR (0.62) AXLKDRMETAURKBLCK
SCHEMBL1888432 0.83 KDR (0.64) AXLKDRMETAURKBLCK
SCHEMBL12503503 0.82 KDR (0.64) AXLKDRMETAURKBLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed